 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (March 2009) |
 |
This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. Please improve this article by introducing more precise citations where appropriate. (March 2009) |
The Texas A&M Institute for Genomic Medicine (TIGM) is an independent 501(c)(3) non-profit institute founded in 2005 under a $50 million award from the Texas Enterprise Fund to pioneer the development of life-changing medical breakthroughs, accelerate the pace of medical discoveries and foster the development of the biotechnology industry in Texas. To that end, TIGM helps researchers gain faster access to the genetically engineered knockout mice they need to help speed research to find the cure for human diseases and conditions. TIGM owns and maintains the world’s largest library of embryonic stem cells for C57BL/6 mice in the world. In addition, TIGM has contracted access to the world’s largest library of genetically modified 129 mouse cells. The Institute headquarters and laboratory facilities are based in the Texas Medical Center in Houston.[1]
References
- ^ "Contact Us." Texas A&M Institute for Genomic Medicine. Retrieved on March 24, 2009.
External links
 |
This Texas A&M University-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
